{"References": [{"title": "T-cell receptor gene therapy for cancer: ready to go viral?", "authors": "June, C. H., Riddell, S. R., Schumacher, T. N.", "journal": "Nature Reviews Immunology", "year": "2015", "volumes": "15", "first page": "615", "last page": "625", "DOI": "10.1038/nri3910"}, {"title": "Neoantigens in cancer immunotherapy", "authors": "Schumacher, T. N., Schreiber, R. D.", "journal": "Science", "year": "2015", "volumes": "348", "first page": "69", "last page": "74", "DOI": "10.1126/science.aaa4971"}, {"title": "Adoptive T cell therapy: new options for cancer treatment", "authors": "Rosenberg, S. A., Restifo, N. P.", "journal": "Immunity", "year": "2015", "volumes": "44", "first page": "435", "last page": "441", "DOI": "10.1016/j.immuni.2016.02.005"}, {"title": "Targeting neoantigens to augment antitumour immunity", "authors": "Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L.", "journal": "Nature Reviews Cancer", "year": "2017", "volumes": "17", "first page": "209", "last page": "222", "DOI": "10.1038/nrc.2016.154"}, {"title": "T cell receptor mimic antibodies for cancer therapy", "authors": "Dao, T., Yan, S., Veomett, N., Pankov, D., Zhou, L., Korontsvit, T., Scott, A., Whitten, J., Maslak, P., Casey, E.", "journal": "Nature Biotechnology", "year": "2015", "volumes": "33", "first page": "1250", "last page": "1255", "DOI": "10.1038/nbt.3379"}, {"title": "The promise of neoantigen-based cancer immunotherapy", "authors": "Blass, E., Ott, P. A.", "journal": "Clinical Cancer Research", "year": "2021", "volumes": "27", "first page": "4473", "last page": "4481", "DOI": "10.1158/1078-0432.CCR-20-4550"}, {"title": "Adoptive cell therapy: harnessing the immune system to battle cancer", "authors": "Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., Dudley, M. E.", "journal": "Nature Reviews Cancer", "year": "2008", "volumes": "8", "first page": "299", "last page": "308", "DOI": "10.1038/nrc2351"}, {"title": "Neoantigen-targeted T cell immunotherapy of cancer", "authors": "Tran, E., Robbins, P. F., Rosenberg, S. A.", "journal": "Cancer Immunology Research", "year": "2017", "volumes": "5", "first page": "528", "last page": "534", "DOI": "10.1158/2326-6066.CIR-17-0005"}, {"title": "TCR-engineered T cells in cancer treatment: achievements and challenges", "authors": "Rapoport, A. P., Stadtmauer, E. A., Binder-Scholl, G. K., Goloubeva, O., Vogl, D. T., Lacey, S. F., Badros, A. Z., Garfall, A., Weiss, B., Finklestein, J.", "journal": "Nature Medicine", "year": "2015", "volumes": "21", "first page": "682", "last page": "688", "DOI": "10.1038/nm.3889"}, {"title": "The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer", "authors": "Yarchoan, M., Hopkins, A., Jaffee, E. M.", "journal": "Clinical Cancer Research", "year": "2017", "volumes": "23", "first page": "4479", "last page": "4484", "DOI": "10.1158/1078-0432.CCR-16-3111"}]}